Recent review articles about ovarian cancer (InTextoResearch)

InTextoResearch, scientific information agency

InTextoResearch informs on the most recent review articles about
ovarian cancer:

Management of ovarian stromal cell tumors.
Colombo N, Parma G, Zanagnolo V, Insinga A.
J Clin Oncol. 2007 Jul 10;25(20):2944-51.

Management of ovarian germ cell tumors.
Gershenson DM.
J Clin Oncol. 2007 Jul 10;25(20):2938-43.

Management of borderline ovarian neoplasms.
Cadron I, Leunen K, Van Gorp T, Amant F, Neven P, Vergote I.
J Clin Oncol. 2007 Jul 10;25(20):2928-37.

Risk-reducing salpingo-oophorectomy in patients with germline
mutations in BRCA1 or BRCA2.
Kauff ND, Barakat RR.
J Clin Oncol. 2007 Jul 10;25(20):2921-7.

Adjuvant chemotherapy for early-stage ovarian cancer: review of the
literature.
Trope C, Kaern J.
J Clin Oncol. 2007 Jul 10;25(20):2909-20.

Experience with bevacizumab in the management of epithelial ovarian
cancer.
Burger RA.
J Clin Oncol. 2007 Jul 10;25(20):2902-8.

Novel approaches in advancing the treatment of epithelial ovarian
cancer: the role of angiogenesis inhibition.
Martin L, Schilder R.
J Clin Oncol. 2007 Jul 10;25(20):2894-901.

Immunologic approaches to ovarian cancer treatment.
Sabbatini P, Odunsi K.
J Clin Oncol. 2007 Jul 10;25(20):2884-93.

Role of surgery in ovarian carcinoma.
Fader AN, Rose PG.
J Clin Oncol. 2007 Jul 10;25(20):2873-83.

Intraperitoneal chemotherapy for ovarian cancer: overview and
perspective.
Rao G, Crispens M, Rothenberg ML.
J Clin Oncol. 2007 Jul 10;25(20):2867-72.

Resistance to chemotherapy in ovarian carcinoma.
Lage H, Denkert C.
Recent Results Cancer Res. 2007;176:51-60.

Epithelial-mesenchymal transition in ovarian cancer progression: a
crucial role for the endothelin axis.
Bagnato A, Rosano L.
Cells Tissues Organs. 2007;185(1-3):85-94.

Evidence-based research for intraperitoneal chemotherapy in epithelial
ovarian cancer.
Almadrones L.
Clin J Oncol Nurs. 2007 Apr;11(2):211-6.

Ovarian cancer: an overview of treatment options.
Martin VR.
Clin J Oncol Nurs. 2007 Apr;11(2):201-7.

Primary ovarian leiomyosarcoma: a review of the clinical and
immunohistochemical features of the rare tumor.
Taskin S, Taskin EA, Uzum N, Ataoglu O, Ortac F.
Obstet Gynecol Surv. 2007 Jul;62(7):480-6.

Follicle stimulating hormone receptor (FSHR) antagonist and epithelial
ovarian cancer (EOC).
Bose CK.
J Exp Ther Oncol. 2007;6(3):201-4.

Current management strategies for ovarian cancer.
Aletti GD, Gallenberg MM, Cliby WA, Jatoi A, Hartmann LC.
Mayo Clin Proc. 2007 Jun;82(6):751-70.

The management of recurrent ovarian cancer.
Bukowski RM, Ozols RF, Markman M.
Semin Oncol. 2007 Apr;34(2 Suppl 2):S1-15.

Intraperitoneal chemotherapy as first-line treatment in the management
of epithelial ovarian cancer.
Rekhraj S, Kinross J, Prabhudesai S, Darzi A, Ziprin P.
Mini Rev Med Chem. 2007 May;7(5):509-17.

Effectiveness of preventive interventions in BRCA1/2 gene mutation
carriers: a systematic review.
Bermejo-Perez MJ, Marquez-Calderon S, Llanos-Mendez A.
Int J Cancer. 2007 Jul 15;121(2):225-31.

Gonadotropins and ovarian cancer.
Choi JH, Wong AS, Huang HF, Leung PC.
Endocr Rev. 2007 Jun;28(4):440-61.

Germ cell tumours of the ovary.
Guillem V, Poveda A.
Clin Transl Oncol. 2007 Apr;9(4):237-43.

The outcomes of ovarian cancer treatment are better when provided by
gynecologic oncologists and in specialized hospitals: a systematic
review.
Vernooij F, Heintz P, Witteveen E, van der Graaf Y.
Gynecol Oncol. 2007 Jun;105(3):801-12.

The role of intraperitoneal therapy in advanced ovarian cancer.
Hess LM, Alberts DS.
Oncology (Williston Park). 2007 Feb;21(2):227-32


(contact pour InTextoResearch: Marc Lacroix, Baelen, Wallonia, Belgium
- scimedweb@xxxxxxxx)

.

Relevant Pages
Loading